Cancer Gene Therapy · 2022 · 11 citations · 22 references
MedicineMolecular BiologyOncologyCancer GeneticsMetastasisMolecular OncologyCancer Cell SignalingCancer ProgressionEsophageal CancerNoncoding Rna BiologyNoncoding Rna In CancerSquamous Cell CarcinomaCancer-related Noncoding Rna FunctionCytoskeletal Remodeling In MigrationLong Noncoding Rna BiomarkersNoncoding Rna In MetastasisTherapeutic Target Identification
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors in China. However, there are no targets to treat ESCC because the molecular mechanism behind the cancer is still unclear. Here, we found a novel long noncoding RNA LINC02820 was upregulated in ESCC and associated with the ESCC clinicopathological stage. Through a series of functional experiments, we observed that LINC02820 only promoted the migration and invasion capabilities of ESCC cell lines. Mechanically, we found that LINC02820 may affect the cytoskeletal remodeling, interact with splice factor 3B subunit 3 (SF3B3), and cooperate with TNFα to amplify the NF-κB signaling pathway, which can lead to ESCC metastasis. Overall, our findings revealed that LINC02820 is a potential biomarker and therapeutic target for the diagnosis and treatment of ESCC.
22
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Ruimei Feng, Yi‐Nan Zong, Su‐Mei Cao et al. · Cancer Communications · 2019 · 1.7K citations · Full text
Medicine, Oncology, Cancer Control +13